Patent ID: 11950903
Assignee: SENSEONICS, INCORPORATED
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 0:
1. An analyte monitoring method comprising:
using an analyte monitoring sensor of an analyte monitoring system to measure glucose levels of a patient, wherein using the analyte monitoring sensor of the analyte monitoring system to measure the glucose levels of the patient comprises using a fluorometer of the analyte monitoring sensor to measure the glucose levels of the patient, using the fluorometer of the analyte monitoring sensor to measure the glucose levels of the patient comprises using the fluorometer to measure parameters of fluorescence after and/or during excitation by a spectrum of light, and the measured parameters include an intensity and/or a wavelength distribution of emission spectrum of the fluorescence;
using the analyte monitoring sensor to communicate over a wireless communication link;
using an analyte monitoring device of the analyte monitoring system to obtain a first glucose measurement indicative of a first glucose level of the patient;
using the analyte monitoring device to obtain a second glucose measurement indicative of a second glucose level of the patient;
using the analyte monitoring device to add the first and the second glucose measurements to a glucose measurement data set;
using a processor of the analyte monitoring device to calculate an estimated HbA1c level using the glucose measurement data set, an association constant k2, and an association constant k3, wherein the association constant k2 represents a conversion of a pre-A1c to an HbA1c, and the association constant k3 represents a life span of the pre-A1c and the HbA1c; and
using a display of the analyte monitoring device to display the estimated HbA1c level.